Internal Medicine, Medical Oncology · Las Vegas, NV
NPI
1538268438
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3730 S Eastern Ave
Las Vegas, NV, 89169
Phone (702) 952-3400
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.6M
198,258 services
Medicare patients, 2024
655
Average age 75
Drug cost, 2024
$3.6M
1,139 prescriptions
Company payments, 2025
$300K
From 37 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Fadi S Braiteh was code J1453 (injection, fosaprepitant, 1 mg), 24,900 times for 40 patients. In total Fadi S Braiteh billed 198,258 services in 190 codes, and Medicare paid $3.6M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1453 Injection, fosaprepitant, 1 mg | Office | 24,900 | 40 | $0.11 | $2,672 |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 19,000 | 18 | $0.05 | $1,033 |
| Q5110 Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | Office | 18,660 | 14 | $0.22 | $4,139 |
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 15,300 | 18 | $0.27 | $4,103 |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 14,500 | 20 | $2.35 | $34K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 7,900 | 76 | $0.10 | $756 |
| J0897 Injection, denosumab, 1 mg | Office | 5,940 | 49 | $20.39 | $121K |
| J0461 Injection, atropine sulfate, 0.01 mg | Office | 2,800 | 17 | $0.06 | $168 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,348 | 64 | $0.09 | $206 |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 2,310 | 14 | $36.59 | $85K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 2,010 | 45 | $0.68 | $1,376 |
| 85025 Blood Count | Office | 1,016 | 209 | $7.54 | $7,662 |
| J9190 Injection, fluorouracil, 500 mg | Office | 1,004 | 28 | $2.30 | $2,312 |
| 36415 Venipuncture Blood Collection | Office | 949 | 205 | $8.57 | $8,129 |
| 80053 Clinical Chemistry | Office | 934 | 205 | $10.27 | $9,591 |
By year: 2022 $3.3M for 221,627 services; 2023 $3.2M for 220,785 services; 2024 $3.6M for 198,258 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,016 | 209 | $7.54 | $7,662 |
| 36415 Venipuncture Blood Collection | 949 | 205 | $8.57 | $8,129 |
| 80053 Clinical Chemistry | 934 | 205 | $10.27 | $9,591 |
| 83615 Clinical Chemistry | 681 | 196 | $5.86 | $3,994 |
| 83540 Clinical Chemistry | 510 | 178 | $6.33 | $3,227 |
| 82728 Clinical Chemistry | 510 | 178 | $13.31 | $6,787 |
| 83550 Clinical Chemistry | 510 | 178 | $8.54 | $4,355 |
| 84439 Clinical Chemistry | 363 | 137 | $8.84 | $3,209 |
| 84443 Clinical Chemistry | 351 | 135 | $16.46 | $5,777 |
| 82378 Clinical Chemistry | 321 | 94 | $18.37 | $5,897 |
Medicare prescription drug claims, 2024
In 2024, the drug Fadi S Braiteh prescribed most often to Medicare patients was Levothyroxine Sodium, with 81 prescriptions and refills. In total Fadi S Braiteh wrote 1,139 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 81 | 138 | 23 | $969 |
| Gabapentin Generic | 80 | 94 | 16 | $851 |
| Prochlorperazine Maleate Generic | 59 | 59 | 31 | $727 |
| Minocycline Hcl Generic | 57 | 67 | 12 | $1,827 |
| Anastrozole Generic | 48 | 101 | 16 | $708 |
| Ondansetron Hcl Generic | 47 | 47 | 30 | $493 |
| Letrozole Generic | 43 | 77 | Under 11 | $508 |
| Tamoxifen Citrate Generic | 38 | 74 | Under 11 | $691 |
| Potassium Chloride Generic | 33 | 43 | Under 11 | $564 |
| Creon Lipase/Protease/Amylase | 33 | 38 | Under 11 | $48K |
| Oxycodone Hcl Generic | 32 | 32 | 13 | $755 |
| Morphine Sulfate Er Morphine Sulfate | 28 | 28 | Under 11 | $663 |
| Alendronate Sodium Generic | 28 | 78 | 12 | $81.35 |
| Olanzapine Generic | 26 | 28 | Under 11 | $132 |
| Erleada Apalutamide | 24 | 24 | Under 11 | $340K |
Brand drugs: 271 claims; generic drugs: 868 claims; opioid claims: 65.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Fadi S Braiteh $300K ($300K in general payments such as food, travel and fees) from 37 companies. The largest payer was Lilly USA, LLC with $62K.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 52 | $62K |
| Jazz Pharmaceuticals Inc. JAZZ | 60 | $59K |
| BeOne Medicines USA, Inc. ONC | 35 | $31K |
| Regeneron Healthcare Solutions, Inc. REGN | 32 | $28K |
| Incyte Corporation INCY | 30 | $26K |
| E.R. Squibb & Sons, L.L.C. BMY | 17 | $26K |
| Taiho Oncology, Inc. 4578.T | 25 | $25K |
| Amgen Inc. AMGN | 10 | $11K |
| Astellas Pharma US Inc 4503.T | 12 | $10K |
| BeiGene USA, Inc. ONC | 10 | $6,965 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.